This study is, to our knowledge, the first to report that Lrp1 is a co-activator of Pparγ and that depletion of Lrp1 in endothelium regulates global energy homeostasis and alleviates some metabolic syndromes, such as obesity and insulin resistance. Here, PPARG is linked to metabolic syndrome.